HAL (France)open access
Health-Related Quality of Life of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab in KEYNOTE-629
Pembrolizumab, Quality of life, Squamous cell carcinoma, Cancer, Immunotherapy, 0, Clinical trial
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 126710
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.